Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

ClinicalTrials.gov ID: NCT00334880

Public ClinicalTrials.gov record NCT00334880. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Parallel-Group, Forced Dose Titration, Safety and Efficacy Study of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and effectiveness of NRP104 administered as a daily morning dose (30, 50, and 70mg/day) compared to placebo in adults (18-55 years of age inclusive) diagnosed with moderate to severe Attention Deficit Hyperactivity Disorder (ADHD).

Study identification

NCT ID
NCT00334880
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
New River Pharmaceuticals
Industry
Enrollment
420 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2006
Primary completion
Not listed
Completion
Oct 31, 2006
Last update posted
Jul 1, 2009

2006

United States locations

U.S. sites
48
U.S. states
23
U.S. cities
46
Facility City State ZIP Site status
Clinical Study Centers, LLC Little Rock Arkansas 72205
Valley Clinical Research, Inc. El Centro California 92243
University of California, Irvine Child Development Center Irvine California 92612
Bay Area Research Institute Lafayette California 94549
Peninsula Research Associates Rolling Hills Estate California 90274
University of California, San Francisco, Dept. of Psychiatry San Francisco California 94143
Encompass Clinical Research Spring Valley California 91978
Alpine Clinical Research Center Boulder Colorado 80304
Yale University School of Medicine New Haven Connecticut 06511
Psychiatric Medicine Center New London Connecticut 06320
Gulfcoast Clinical Research Center Fort Myers Florida 33912
Miami Research Associates Miami Florida 33173
Clinical Neuroscience Solutions, Inc. Orlando Florida 32806
Meridien Research Tampa Florida 33606
Janus Center for Psychiatric Research LLC West Palm Beach Florida 33407
Northwest Behavioral Research Center Roswell Georgia 30076
Carman Research Smyrna Georgia 30080
Psychiatric Associates Overland Park Kansas 66211
Vince and Associates Clinical Research Overland Park Kansas 66212
Johns Hopkins at Green Spring Station Lutherville Maryland 21093
Marc Hertzman, MD Rockville Maryland 20852
Massachusetts General Hospital Cambridge Massachusetts 02138
Summit Research Network (Michigan) Inc. Flint Michigan 48507
Rochester Center for Behavioral Medicine Rochester Hills Michigan 48307
St Charles Psychiatric Associates-Midwest Research Saint Charles Missouri 63301
Mercy Health Research St Louis Missouri 63141
Center for Psychiatry and Behavioral Medicine Las Vegas Nevada 89128
CNS Research Institute (CRI) Clementon New Jersey 08021
VA NY Harbor Healthcare System New York New York 10010
Duke University ADHD Program Durham North Carolina 27705
Richard Weisler and Associates Raleigh North Carolina 27609
University Hospitals of Cleveland, Case Western Reserve University Cleveland Ohio 44106
The Ohio State University Columbus Ohio 43210
IPS Research Company Oklahoma City Oklahoma 73103
Oregon Center for Clinical Investigations, Inc. Portland Oregon 97210-2659
CNS Research Institute, P.C. Philadelphia Pennsylvania 19149
FutureSearch Trials Austin Texas 78756
Claghorn-Lesem Research Clinic Bellaire Texas 77401
Bayou City Research Houston Texas 77007
Red Oak Psychiatry Associates, P.A. Houston Texas 77090
R/D Clinical Research, Inc. Lake Jackson Texas 77566
John M. Turnbow, MD, PA Lubbock Texas 79423
The Clinical Study Center Burlington Vermont 05401
Neuropsychiatric Associates Woodstock Vermont 05091
Psychiatric Alliance of the Blue Ridge Clinical Research Charlottesville Virginia 22903
NeuroScience, Inc. Herndon Virginia 20170
Brighton Research Group Virginia Beach Virginia 23452
Summit Research Network LLC (Seattle) Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00334880, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 1, 2009 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00334880 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →